News

Ervebo is a recombinant, replication-competent Ebola vaccine, originally developed by NewLink Genetics and licensed to Merck in 2014, that has been given to hundreds of thousands of people in the ...
A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.
This is the second Ebola vaccine approved by the European Commission: in November it granted a marketing authorisation to MSD’s vaccine known as Ervebo. This vaccine has been shown to produce ...
Most Americans have encountered false claims about the measles vaccine, and many aren’t sure what the truth is, according to a KFF poll released Wednesday. Misconceptions about measles ...
HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told ...
April 23 (Reuters) - Most adults and parents have read or heard false claims about measles and the measles vaccine, leaving many unsure of what to believe, a poll by the nonprofit organization KFF ...
Dr. Ali Sherif normally gives about 50 doses of the measles vaccine to children each month at his clinic in Hobbs, New Mexico, near the Texas state line. The number of shots at his clinic has ...
A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...
The Covid vaccines made by Pfizer and Moderna helped lift the world out of the pandemic, but a small group of people were left with debilitating side effects that they attribute to the vaccine.
Even as the number of national cases has exceeded 800 and two children have died, “false and misleading statements” regarding the measles virus and vaccines used to target measles have ...